Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice

Endocrinology

Volumn 142, Issue 7, 2001, Pages 3198-3206

  Reese, Jeff ^a   Zhao, Xuemei ^a   Ma, Wen Ge ^a   Brown, Naoko ^a   Maziasz, Timothy J ^b   Dey, S K ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; FEMALE GENITAL SYSTEM; GENE EXPRESSION REGULATION; GENE TARGETING; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REPRODUCTION;

EID: 0034984922     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.7.8307     Document Type: Article

References (47)

1. Endocrine control of egg implantation
2. Multiple female reproductive failures in cyclooxygenase 2-defident mice
3. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ
4. Molecular signaling in uterine receptivity for implantation
5. Cyclooxygenase in biology and disease
6. Cyclooxygenases 1 and 2
7. Prostaglandin endoperoxide H synthases-1 and -2
8. Identification of a phorbol ester-repressible v-src-inducible gene
9. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
10. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein
11. Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary
12. Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor
13. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
14. Cox-2-selective inhibitors: The new super aspirins
15. Cydooxygenase 2 inhibitors: Discovery, selectivity and the future
16. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
17. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
18. Molecular mechanisms of ovulation and luteinization
19. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1β
20. Regulation of plasminogen activator in rat endometrial stromal cells: The role of prostaglandin E2
21. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids
22. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
23. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor
24. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
25. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse
26. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cydooxygenase-1 and cyclooxygenase-2
27. Reduction of fertility of mice by the intrauterine injection of prostaglandin antagonists
28. Infertility may sometimes be associated with NSAID consumption
29. Influence of prostaglandins and platelet activating factor on implantation
30. Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs
31. A new case of NSAID-induced infertility
32. 4 triggers remodelling of the cardiovascular system at birth
33. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
34. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation
35. Ovulation
36. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor
37. Dysregulation of EGF family of growth factors and cydooxygenase-2 in the uterus during the preattachment and attachment reactions of the blastocysts with the luminal epithelium correlates with implantation failure in LIF deficient mice
38. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor
39. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: A possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation
40. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation
41. COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period
42. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
43. Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats
44. Aspirin induces increased expression of both prostaglandin H synthase-1 and prostaglandin H synthase-2 in cultured human placental trophoblast
45. Peroxisome proliferators enhance cydooxygenase-2 expression in epithelial cells
46. Combinatorial chemoprevention of intestinal neoplasia